CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 4 Open-market sale CFO sold 1,427 shares at $2.76 ($3,939)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale EVP, CMO sold 1,408 shares at $2.69 ($3,788)
- 4 Open-market sale President and CEO sold 4,571 shares at $2.69 ($12,296)
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Open-market sale EVP, CMO sold 2,092 shares at $1.88 ($3,933)
- 4 Open-market sale President and CEO sold 7,543 shares at $1.88 ($14,181)
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Acquisition or sale completed · Other events
- 8-K Event Material agreement · Agreement ended · Regulation FD disclosure
Page 35 of 68 · 1,358 filings